11-65557854-CCAGCAGCAGCAGCAGCAGCAG-CCAGCAGCAGCAGCAGCAGCAGCAGCAG
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001130144.3(LTBP3):c.100_105dupCTGCTG(p.Leu34_Leu35dup) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.154 in 1,318,248 control chromosomes in the GnomAD database, including 7,553 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.12 ( 1439 hom., cov: 27)
Exomes 𝑓: 0.16 ( 6114 hom. )
Consequence
LTBP3
NM_001130144.3 conservative_inframe_insertion
NM_001130144.3 conservative_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.342
Genes affected
LTBP3 (HGNC:6716): (latent transforming growth factor beta binding protein 3) The protein encoded by this gene forms a complex with transforming growth factor beta (TGF-beta) proteins and may be involved in their subcellular localization. Activation of this complex requires removal of the encoded binding protein. This protein also may play a structural role in the extracellular matrix. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 11-65557854-C-CCAGCAG is Benign according to our data. Variant chr11-65557854-C-CCAGCAG is described in ClinVar as [Benign]. Clinvar id is 403062.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.178 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LTBP3 | NM_001130144.3 | c.100_105dupCTGCTG | p.Leu34_Leu35dup | conservative_inframe_insertion | 1/28 | ENST00000301873.11 | NP_001123616.1 | |
LTBP3 | NM_021070.4 | c.100_105dupCTGCTG | p.Leu34_Leu35dup | conservative_inframe_insertion | 1/27 | NP_066548.2 | ||
LTBP3 | NM_001164266.1 | c.-248_-243dupCTGCTG | 5_prime_UTR_variant | 1/27 | NP_001157738.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LTBP3 | ENST00000301873.11 | c.100_105dupCTGCTG | p.Leu34_Leu35dup | conservative_inframe_insertion | 1/28 | 2 | NM_001130144.3 | ENSP00000301873.5 |
Frequencies
GnomAD3 genomes AF: 0.124 AC: 18558AN: 149128Hom.: 1441 Cov.: 27
GnomAD3 genomes
AF:
AC:
18558
AN:
149128
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0772 AC: 2549AN: 33030Hom.: 78 AF XY: 0.0816 AC XY: 1564AN XY: 19164
GnomAD3 exomes
AF:
AC:
2549
AN:
33030
Hom.:
AF XY:
AC XY:
1564
AN XY:
19164
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.158 AC: 184412AN: 1169030Hom.: 6114 Cov.: 26 AF XY: 0.157 AC XY: 89622AN XY: 571230
GnomAD4 exome
AF:
AC:
184412
AN:
1169030
Hom.:
Cov.:
26
AF XY:
AC XY:
89622
AN XY:
571230
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.124 AC: 18545AN: 149218Hom.: 1439 Cov.: 27 AF XY: 0.118 AC XY: 8597AN XY: 72830
GnomAD4 genome
AF:
AC:
18545
AN:
149218
Hom.:
Cov.:
27
AF XY:
AC XY:
8597
AN XY:
72830
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Brachyolmia-amelogenesis imperfecta syndrome;C4540511:Geleophysic dysplasia 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 02, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Brachyolmia-amelogenesis imperfecta syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at